你怎么看这家公司？
应用层生命科学成立于 2017
Shenzhen Ruixin Intelligent Medical Technology Co., Ltd., founded in December 2017 by three returnee PhDs — Zheng Lingxiao, Lan Hongzhi, and Ma Jun — develops an AI and surgical robotics precision diagnosis and treatment platform for cardiovascular and cerebrovascular diseases. Core products include Ruixin Score (CT-FFR non-invasive coronary functional assessment), AngioQFA coronary functional measurement system, and intracardiac ultrasound, with an AI vascular interventional surgical robot under development; the company holds 11 NMPA registration certificates and EU CE certification, with clinical partnerships at over 800 hospitals.
资本关系图
创始人 / 核心团队
投资方
融资历史
- 2026-07战略投资